Speeding up drug discovery for brain diseases
Whitehead Institute team finds drugs that activate a key brain gene; initial tests in cells and mice show promise for rare, untreatable neurodevelopmental disorder.
Whitehead Institute team finds drugs that activate a key brain gene; initial tests in cells and mice show promise for rare, untreatable neurodevelopmental disorder.
By turning molecular structures into sounds, researchers gain insight into protein structures and create new variations.
Fluorescent tagging system can expedite the process of designing genes and personalizing medicine.
Researchers have devised a faster, more efficient way to design custom peptides and perturb protein-protein interactions.
Technique could yield insights into complex proteins involved in Alzheimer’s and other diseases.
Picower Institute researchers find that a key protein linked to intellectual disability shapes electrical currents in neural connections.
By making hydrophobic sections water-soluble, researchers hope to learn more about protein structures.
Study reveals atomic structure of tropoelastin, showing what goes wrong in some diseases.
Researchers identify the molecular structure of the GATOR1 protein complex, which regulates growth signals in human cells, using cryo-electron microscopy.
Modified carbon nanotubes could be used to track protein production by individual cells.
Professor Barbara Imperiali creates better biochemical tools for basic biology and drug development.
New technique could contribute to efforts to map the human brain.
New protein nanoparticles allow scientists to track cells and interactions within them.
Enhanced-sensitivity NMR could reveal new clues to how proteins fold.
MIT physics graduate student James Owen Andrews is developing software to improve dynamic image capture from super-resolution fluorescent microscopes.